01 1Cambrex Profarmaco Milano Srl
01 1Sam-O Pharmaceutical Co., Ltd.
01 1Glybenclamide
01 1U.S.A
Registrant Name : Sam-O Pharmaceutical Co., Ltd.
Registration Date : 2022-08-01
Registration Number : 20220801-209-J-1337
Manufacturer Name : Cambrex Profarmaco Milano Sr...
Manufacturer Address : Via Curiel, 34 – 20067 Paullo (Milan) Italy
74
PharmaCompass offers a list of Glibenclamide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Glibenclamide manufacturer or Glibenclamide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Glibenclamide manufacturer or Glibenclamide supplier.
A Glidiabet manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Glidiabet, including repackagers and relabelers. The FDA regulates Glidiabet manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Glidiabet API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Glidiabet manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Glidiabet supplier is an individual or a company that provides Glidiabet active pharmaceutical ingredient (API) or Glidiabet finished formulations upon request. The Glidiabet suppliers may include Glidiabet API manufacturers, exporters, distributors and traders.
click here to find a list of Glidiabet suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Glidiabet Drug Master File in Korea (Glidiabet KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Glidiabet. The MFDS reviews the Glidiabet KDMF as part of the drug registration process and uses the information provided in the Glidiabet KDMF to evaluate the safety and efficacy of the drug.
After submitting a Glidiabet KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Glidiabet API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Glidiabet suppliers with KDMF on PharmaCompass.
We have 1 companies offering Glidiabet
Get in contact with the supplier of your choice:
